Skip to main content

Table 1 Summary of Neuroblastoma Endpoints

From: HetEnc: a deep learning predictive model for multi-type biological dataset

Endpoint FAV OS_All OS_HR
Full description Neuroblastoma Favorable Prognosis Overall Survival Survival in High Risk patients
Sample size (Train/Test) 136/136 249/249 86/90
Train set prevalence 45/91 (0.669) 51/198 (0.795) 43/43 (0.500)
Test set prevalence 46/90 (0.662) 54/195 (0.783) 49/41 (0.544)
Predicting difficulty
(Zhang, et al., 2015)
Easy Medium Hard